MRI Interventions, Inc. Reports 26% Year-Over-Year Increase in Third Quarter Procedures
Nov 06, 2017 21:05 pm UTC| Business
Gross Margin Increases to 60% Record 469 ClearPoint Procedures Performed Year-to-Date IRVINE, Calif., Nov. 06, 2017 -- MRI Interventions, Inc. (OTCQB:MRIC) (the “Company”) today announced financial results for the...
TRACON Pharmaceuticals to Present at Upcoming Investment Conferences
Nov 06, 2017 21:05 pm UTC| Business
SAN DIEGO, Nov. 06, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
TrueCar Reports Third Quarter 2017 Financial Results
Nov 06, 2017 21:03 pm UTC| Business
Third quarter total revenue up 10% from a year ago to $82.4 million.Third quarter net loss of $(9.5) million, or $(0.10) per share, compared to net loss of $(7.4) million, or $(0.09) per share, in the third quarter of...
Nov 06, 2017 21:03 pm UTC| Business
- FDA decision on New Drug Application expected by June 30, 2018 - Licensed exclusive, worldwide rights to lebrikizumab from Roche - Completed patient enrollment in two Phase 3 trials for the treatment of acne...
Idera Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Corporate Update
Nov 06, 2017 21:02 pm UTC| Business
– IMO 2125 Translational Data Update at SITC on November 11 –– Completes Public Offering, extends runway into second quarter 2019 – CAMBRIDGE, Mass., Nov. 06, 2017 -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a...
Diamondback Energy, Inc. Announces Third Quarter 2017 Financial and Operating Results
Nov 06, 2017 21:01 pm UTC| Business
MIDLAND, Texas, Nov. 06, 2017 -- Diamondback Energy, Inc. (NASDAQ:FANG) (“Diamondback” or the “Company”) today announced financial and operating results for the third quarter ended September 30, 2017. HIGHLIGHTS Q3...
Portola Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Corporate Update
Nov 06, 2017 21:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2017 -- Portola Pharmaceuticals Inc.® (Nasdaq:PTLA) will today report financial results and provide a corporate update for the quarter ended September 30, 2017. “Following FDA...